- Home
- KELYB vs LRMR Comparison
KELYB vs LRMR Comparison
Compare KELYB & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KELYB | LRMR |
|---|---|---|
| Founded | 1946 | N/A |
| Country | United States | United States |
| Employees | 5570 | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 513.9M | 455.8M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | KELYB | LRMR |
|---|---|---|
| Price | $15.83 | $4.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 6.2K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.72 | N/A |
| Revenue Next Year | N/A | $1,816.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.38 | $1.73 |
| 52 Week High | $125.00 | $6.42 |
Technical Indicators
Market Signals| Indicator | KELYB | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 52.38 | 40.84 |
| Support Level | $11.66 | $4.21 |
| Resistance Level | $17.63 | $4.24 |
| Average True Range (ATR) | 0.81 | 0.23 |
| MACD | -0.10 | -0.08 |
| Stochastic Oscillator | 31.82 | 29.91 |
Price Performance
Historical ComparisonAbout KELYB Kelly Services Inc. Class B
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services to a diverse group of clients operating in the Americas, Europe, and the Asia-Pacific region across various industries. The company's reportable segments are: Enterprise Talent Management, Science, Engineering and Technology, and Education. Maximum revenue is generated from its Enterprise Talent Management segment, which delivers temporary staffing, outcome-based, and permanent placement services focused on light industrial, contact center, and office and clerical specialties in North America across various industries. It also provides talent supply chain and workforce talent solutions, including MSP, RPO, and PPO solutions to its clients. Geographically, it derives key revenue from the USA.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.